APLNR and melanoma: Screens in human melanoma cells have revealed mechanisms mediating susceptibility to in vitro CD8+ T cell killing, including an apelin receptor (APLNR) required for interferon gamma (IFNγ) susceptibility and components of the TNF pathway including TRAF2 (84, 105).